000 01663 a2200469 4500
005 20250513120525.0
264 0 _c19970724
008 199707s 0 0 eng d
022 _a0271-9142
024 7 _a10.1023/a:1027310612323
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBlair, P J
245 0 0 _aImpaired induction of the apoptosis-protective protein Bcl-xL in activated PBMC from asymptomatic HIV-infected individuals.
_h[electronic resource]
260 _bJournal of clinical immunology
_cMay 1997
300 _a234-46 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
650 0 4 _aAntigens, CD
_xbiosynthesis
650 0 4 _aAntigens, Differentiation, T-Lymphocyte
_xbiosynthesis
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aFemale
650 0 4 _aHIV Infections
_ximmunology
650 0 4 _aHumans
650 0 4 _aJurkat Cells
650 0 4 _aLectins, C-Type
650 0 4 _aLeukocytes, Mononuclear
_ximmunology
650 0 4 _aLymphocyte Activation
_xdrug effects
650 0 4 _aMale
650 0 4 _aPokeweed Mitogens
_xpharmacology
650 0 4 _aProto-Oncogene Proteins c-bcl-2
_xbiosynthesis
650 0 4 _abcl-X Protein
700 1 _aBoise, L H
700 1 _aPerfetto, S P
700 1 _aLevine, B L
700 1 _aMcCrary, G
700 1 _aWagner, K F
700 1 _aSt Louis, D C
700 1 _aThompson, C B
700 1 _aSiegel, J N
700 1 _aJune, C H
773 0 _tJournal of clinical immunology
_gvol. 17
_gno. 3
_gp. 234-46
856 4 0 _uhttps://doi.org/10.1023/a:1027310612323
_zAvailable from publisher's website
999 _c9149544
_d9149544